VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FMC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FMCFMC Corporation
$5.63$705M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFMCFinancials

FMC Corporation (FMC) Income Statement

30Y historyFree accessUpdated daily

Revenue fell from $1.1B in 2025Q4 to $105.9M in 2026Q3 while gross margin swung from 42.5% to negative 3.8%, indicating severe pricing and inventory pressure that fixed overhead of roughly $172M per quarter cannot absorb.

Income StatementBalance SheetCash FlowRatios

FMC Income Statement

Annual statement

FMC Income Statement

FMC Corporation (FMC) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue2.87B3.47B4.25B4.49B5.8B5.05B4.64B4.61B4.29B2.88B3.28B3.28B3.26B3.87B3.75B3.38B3.12B2.83B3.12B2.63B2.35B2.15B2.05B1.92B1.85B1.94B3.93B4.11B4.38B4.31B5.08B
Revenue Growth %-19.33%-18.34%-5.36%-22.67%15.01%8.68%0.7%7.57%48.87%-12.3%0.18%0.55%-15.9%3.37%10.97%8.39%10.26%-9.28%18.32%12.18%9.15%4.83%6.76%3.7%-4.64%-50.5%-4.5%-6.12%1.53%-15.12%12.66%
Cost of Goods Sold2.2B2.18B2.67B2.58B3.42B2.86B2.58B2.62B2.37B1.75B1.59B2.16B2.09B2.55B2.42B2.21B2.07B1.86B2.13B1.83B1.64B1.51B1.47B1.4B1.36B1.41B2.68B2.83B3.04B2.95B3.47B
COGS % of Revenue-63%62.85%57.47%58.86%56.66%55.51%56.8%55.2%60.87%48.39%65.78%64.1%65.7%64.52%65.3%66.51%65.81%68.51%69.51%69.73%70.15%71.87%72.89%73.39%72.5%68.35%68.79%69.37%68.45%68.33%
Gross Profit670.1M1.28B1.58B1.91B2.39B2.19B2.07B1.99B1.92B1.13B950.6M1.12B1.17B1.33B1.33B1.17B1.04B966.3M980.9M802.8M709.4M641.8M577M520.9M493M534.3M1.24B1.28B1.34B1.36B1.61B
Gross Margin %23.36%37%37.15%42.53%41.14%43.34%44.49%43.2%44.8%39.13%28.96%34.22%35.9%34.3%35.48%34.71%33.49%34.19%31.49%30.49%30.23%29.85%28.13%27.11%26.61%27.5%31.65%31.21%30.63%31.55%31.67%
Gross Profit Growth %--18.66%-17.35%-20.05%9.16%5.87%3.71%3.75%70.44%18.48%-15.22%-4.16%-11.96%-0.08%13.44%12.31%8.02%-1.49%22.18%13.17%10.53%11.23%10.77%5.66%-7.73%-56.99%-3.16%-4.33%-1.44%-15.43%12.77%
Operating Expenses3.16B3.17B922.6M1.07B1.1B1.02B945M1.02B982.8M621.7M573.8M616.6M581.4M629.2M644.9M547.7M504.4M415.1M430.6M409.9M381.8M364.8M348.2M324.3M306.1M666.2M865.9M908.5M977M1.04B1.14B
OpEx % of Revenue-91.41%21.73%23.86%18.89%20.22%20.36%22.02%22.93%21.6%17.48%18.82%17.84%16.24%17.21%16.21%16.19%14.69%13.82%15.57%16.27%16.97%16.98%16.88%16.52%34.29%22.06%22.1%22.31%24.06%22.37%
Selling, General & Admin705.2M684.9M644.6M741.6M781.7M715.4M657.1M717M695.1M480.2M439.3M472.9M455.1M511.5M527.1M442.5M403.9M322.3M336.8M315.3M284.9M270.4M254.8M236.9M224.1M566.4M522.5M575.4M612.7M625.3M692.7M
SG&A % of Revenue-19.75%15.18%16.53%13.47%14.18%14.16%15.55%16.22%16.68%13.38%14.43%13.97%13.2%14.06%13.1%12.96%11.4%10.81%11.98%12.14%12.58%12.42%12.33%12.09%29.15%13.31%14%13.99%14.5%13.63%
Research & Development251.3M266.1M278M328.8M314.2M304.7M287.9M298.1M287.7M141.5M141.5M143.7M126.3M117.7M117.8M105.2M100.5M92.8M93.8M94.6M96.9M94.4M93.4M87.4M82M99.8M154.5M152.4M157.7M174M189.4M
R&D % of Revenue-7.67%6.55%7.33%5.42%6.04%6.2%6.47%6.71%4.92%4.31%4.39%3.88%3.04%3.14%3.11%3.23%3.28%3.01%3.59%4.13%4.39%4.55%4.55%4.43%5.14%3.94%3.71%3.6%4.03%3.73%
Other Operating Expenses3M2.22B000000000000000000000000188.9M180.7M206.6M238.4M254.2M
Operating Income-2.49B-1.89B654.7M837.9M1.29B1.17B1.12B976.5M936.9M504.6M376.8M504.6M588.5M699.7M685M624.6M539.4M551.2M550.3M392.9M327.6M277M228.8M24.7M186.9M-504.3M155.9M270.9M170.7M127.2M315.2M
Operating Margin %-86.89%-54.41%15.42%18.67%22.25%23.12%24.14%21.18%21.86%17.53%11.48%15.4%18.06%18.06%18.27%18.49%17.31%19.5%17.66%14.92%13.96%12.88%11.15%1.29%10.09%-25.95%3.97%6.59%3.9%2.95%6.2%
Operating Income Growth %--388.16%-21.86%-35.09%10.66%4.11%14.74%4.23%85.67%33.92%-25.33%-14.26%-15.89%2.15%9.67%15.8%-2.14%0.16%40.06%19.93%18.27%21.07%826.32%-86.78%137.06%-423.48%-42.45%58.7%34.2%-59.64%27.66%
EBITDA-2.34B-1.71B905.7M1.09B1.46B1.33B1.28B1.22B1.09B614.3M492.7M623.1M710.2M833.1M828.6M754.3M687.2M678.4M674.5M526.6M459.4M413.3M363.1M149.3M305.7M-372.7M344.8M451.6M377.3M365.6M569.4M
EBITDA Margin %-81.72%-49.4%21.33%24.27%25.12%26.3%27.55%26.41%25.55%21.34%15.01%19.02%21.79%21.5%22.11%22.33%22.05%24%21.65%20%19.57%19.22%17.7%7.77%16.5%-19.18%8.78%10.99%8.62%8.48%11.21%
EBITDA Growth %-859.28%-289.14%-16.84%-25.27%9.81%3.79%5.03%11.22%78.2%24.68%-20.93%-12.26%-14.75%0.54%9.85%9.76%1.3%0.58%28.09%14.63%11.15%13.83%143.2%-51.16%182.02%-208.09%-23.65%19.69%3.2%-35.79%14.84%
D&A (Non-Cash Add-back)148.1M173.6M251M251.2M166.4M160.6M158.3M241M157.8M109.7M115.9M118.5M121.7M133.4M143.6M129.7M147.8M127.2M124.2M133.7M131.8M136.3M134.3M124.6M118.8M131.6M188.9M180.7M206.6M238.4M254.2M
EBIT-869.7M-258.3M486.4M535M1.13B1.02B878.4M814.7M742.5M260.8M244.3M-49.1M415.2M658.1M658M590M390M337.2M504.8M232.5M262.2M263.1M215.8M196.6M186.9M-131.9M260.2M287.7M364M322.9M338.4M
Net Interest Income-1.66B-1.63B-235.8M-237.2M-151.8M-131.1M-151.2M-158.5M-133.1M-79.1M-62.9M-60.9M-51.2M-36.3M-40.7M-35M-39.3M-27M-31.9M000-222.8M-197.8M-155.4M000000
Interest Income000000100K1.9M1.4M900K600K1.3M0200K100K100K200K000002.5M3.9M1.4M000000
Interest Expense1.66B1.63B235.8M237.2M151.8M131.1M151.3M160.4M134.5M80M63.5M62.2M51.2M36.5M40.8M39.4M39.5M27M31.9M228M251.9M239.5M225.3M201.7M156.8M000000
Other Income/Expense-523.7M0-402.2M-537.7M-307M-268.7M-390.6M-321.5M-328.5M-323.8M-196M-635.1M-224.7M-83.8M-72.4M-74.1M-188.9M-241.2M-78.4M-197.6M-107.4M-76.2M-93.9M-158.6M-100.4M-341M-101.6M-92.6M-114.5M-382.6M-102.6M
Pretax Income-3.02B-1.89B252.5M300.2M983.9M897.8M729.8M655M608.4M180.8M180.8M-130.5M363.8M615.9M612.6M550.5M350.5M310M471.9M195.3M220.2M200.8M134.9M38M86.5M-472.9M222.6M274.3M249.5M-59.7M322.6M
Pretax Margin %-105.15%-54.41%5.95%6.69%16.96%17.8%15.72%14.21%14.2%6.28%5.51%-3.98%11.16%15.9%16.34%16.3%11.25%10.97%15.15%7.42%9.38%9.34%6.58%1.98%4.67%-24.34%5.67%6.67%5.7%-1.38%6.35%
Income Tax1.19B352.3M-150.9M-1.12B145.2M92.5M150.9M111.5M70.8M264.1M50.1M47.4M56.2M148.6M146.7M136.5M132M53M125.4M29M68.3M82.3M-44.5M-1.8M17.4M-166.6M45.3M58.3M64.2M-35.2M104.5M
Effective Tax Rate %-39.57%-18.67%-59.76%-372.85%14.76%10.3%20.68%17.02%11.64%146.07%27.71%-36.32%15.45%24.13%23.95%24.8%37.66%17.1%26.57%14.85%31.02%40.99%-32.99%-4.74%20.12%35.23%20.35%21.25%25.73%58.96%32.39%
Net Income-4.26B-2.24B339.9M1.32B736.5M739.6M552.4M477.4M502.1M535.8M209.1M489M307.5M293.9M416.2M365.9M172.5M228.5M304.6M132.4M132M116.6M160.2M26.5M65.8M-337.7M110.6M212.6M106.5M162.4M210.7M
Net Margin %-148.38%-64.57%8%29.39%12.69%14.66%11.9%10.36%11.72%18.61%6.37%14.92%9.44%7.58%11.1%10.83%5.54%8.09%9.78%5.03%5.62%5.42%7.81%1.38%3.55%-17.38%2.82%5.17%2.43%3.77%4.15%
Net Income Growth %-695.59%-758.69%-74.23%79.06%-0.42%33.89%15.71%-4.92%-6.29%156.24%-57.24%59.02%4.63%-29.38%13.75%112.12%-24.51%-24.98%130.06%0.3%13.21%-27.22%504.53%-59.73%119.48%-405.33%-47.98%99.62%-34.42%-22.92%-2.27%
Net Income (Continuing)-4.21B-2.24B403.4M1.42B838.7M805.3M578.9M543.5M537.6M-83.3M130.7M-177.9M307.6M467.3M465.9M414M218.5M257M346.5M166.3M151.9M118.5M179.4M39.8M69.1M-306.3M125.6M158.7M185.3M-24.5M162.8M
Discontinued Operations-2M0-61.8M-98.5M00000-733.1M0-736.8M0-95.7M-2.7M000000-29.8M000000000
Minority Interest28.9M27.4M21.3M22.5M23M19.4M22.4M29.1M89.3M25.3M35.3M42.6M33.5M52.3M74.5M63.5M57.7M56.7M63.5M58.4M59M51.5M51.1M48.3M44.8M44.8M47M46.2M73.5M58M139.4M
EPS (Diluted)-32.00-17.882.7210.515.805.714.213.603.693.991.563.662.292.163.002.551.181.562.010.860.850.751.070.190.48-1.320.430.820.820.550.69
EPS Growth %-679.25%-757.35%-74.12%81.21%1.58%35.63%16.94%-2.44%-7.52%155.77%-57.38%59.83%6.02%-28%17.65%116.1%-24.36%-22.39%133.72%1.18%13.33%-29.91%463.16%-60.42%136.36%-406.98%-47.56%0%49.09%-20.29%-4.17%
EPS (Basic)--17.882.7310.515.835.754.243.643.743.991.563.662.302.163.012.571.191.582.070.880.860.771.090.190.49-1.340.440.840.820.550.71
Diluted Shares Outstanding133M125.2M125.2M125.53M126.71M129.15M130.58M132M135.9M134.3M134.5M133.7M134.3M136.1M138.8M143.4M146.2M146.6M151.6M154.85M154.58M155.53M150.21M141.33M137.08M256.04M256.04M259.02M129.68M139.7M148.72M
Basic Shares Outstanding133M125.2M124.9M125.53M125.97M128.4M129.7M130.76M134.4M134.25M133.9M133.7M133.3M135.2M137.7M142M144.4M144.4M147.6M150.45M152.85M152.32M146.9M141.33M134.29M252.31M252.31M252.13M129.68M139.7M148.72M
Dividend Payout Ratio--85.5%22.03%36.32%33.42%41.37%44.05%17.77%16.57%42.37%17.67%25.4%25.04%11.48%11.26%21.1%15.89%11.29%22.43%15.91%-0.94%11.32%4.26%-2.53%2.78%4.98%4.93%21.31%

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Channel inventory destocking persistence

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Contraction Deepens Through Destocking

Based on reported quarterly figures, FMC's revenue fell from roughly $1.1B in 2025Q4 to $105.9M in 2026Q3, a sharp contraction that suggests distributor channel destocking is overwhelming underlying end-demand trends and warrants close monitoring.

The reported year-over-year revenue decline of 18.34% and the sequential drop into the 2026Q3 quarter point to a volume reset rather than a gradual cyclical slowdown. Because the company's sales are transactional and tied to distributor purchasing, the magnitude of the drop may reflect inventory being run down at the channel level rather than weaker farmer consumption alone. Investors should monitor whether sell-out data to growers stabilizes, since that would separate a temporary inventory correction from a durable loss of demand.

Gross Margin Compression Signals Pricing Strain

As reported in the quarterly income statement, FMC's gross margin fell from 42.5% in 2025Q4 to negative 3.8% in 2026Q3, which may indicate inventory write-downs and weaker pricing power on patented molecules.

The collapse in gross margin is far more severe than the revenue decline alone would explain, which suggests high-cost inventory being liquidated at depressed prices. This pattern is consistent with the aging patent cliff eroding the premium pricing that historically supported margins near 37% to 40%. Whether this represents a transient accounting effect or a structural shift in pricing power cannot be resolved from the data provided and warrants further investigation.

Fixed Opex Absorbs Shrinking Gross Profit

According to the reported figures, SG&A held near $172M in 2026Q3 while gross profit collapsed to negative $401.6M, indicating that overhead is not flexing down with volume and driving operating losses.

Because SG&A and R&D together remain roughly $230M per quarter regardless of revenue, operating leverage is working sharply against the company on the way down. The reported operating margin of negative 54.4% on a trailing basis reflects this mismatch alongside likely non-cash charges. Management's ability to reduce the fixed cost base will be a key determinant of how quickly profitability can return once channel volumes normalize.

Net Losses Outpace Operating Deterioration

Based on FMC's reported figures, net losses of roughly $2.1B in 2026Q3 far exceed the operating loss of $631.6M, suggesting that non-operating or one-time items materially distort reported earnings and EPS of negative $15.54.

The gap between operating and net results is large enough to suggest impairments, tax effects, or other non-recurring charges that do not reflect core chemistry economics. Stock-based compensation is small relative to these losses and does not explain the divergence. Analysts should normalize earnings before relying on trailing EPS for valuation or credit assessment.

Guidance Reset May Signal Deeper Trough

Per the latest guidance, forward revenue of $1.04B to $1.14B sits well below the trailing $3.47B base, which may indicate the channel correction is more structural than the market currently assumes.

The guided revenue step-down, combined with a latest-quarter EPS miss of negative $4.41 against a $0.59 consensus, challenges the view that destocking is nearly complete. If elevated channel inventory persists longer than expected, the generic cliff on diamide franchises could compound the volume loss. The reported 2.00 debt-to-equity figure is also unverified and should be reconciled before drawing conclusions on balance sheet flexibility.

FMC — Frequently Asked Questions

Quick answers to the most common questions about buying FMC stock.

What was FMC Corporation's (FMC) revenue in 2025?

For fiscal year 2025, FMC Corporation (FMC) reported total revenue of $3.47B. This represents a 31.8% decline compared to $5.08B in 1996.

Is FMC Corporation (FMC) profitable?

FMC Corporation (FMC) reported a net loss of $2.24B for the fiscal year ending 2025.

What is FMC Corporation's operating profit margin?

FMC Corporation (FMC) reported an operating income of $-1886.6M, resulting in an operating profit margin of -54.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is FMC Corporation's gross profit and gross margin?

FMC Corporation (FMC) generated $1.28B in gross profit for the year, representing a gross profit margin of 37.0%. This demonstrates the company's core pricing power and production efficiency.